Genmab Announces AbbVie Receives Positive CHMP Opinion for
Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase 1/2 trial evaluating the preliminary efficacy and...
Source: globenewswire.com
📰 Human Use News
Page 58 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
Mirati Therapeutics Provides Update on Regulatory Review in the European Union of KRAZATI (adagrasib) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRAS G12C Mutation
SAN DIEGO and ZUG, Switzerland, July 21, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® , a commercial stage biotechnology company, today announced the European Medicine Agencys Committee for...
United States Exchange Commission Committee For Medicinal Products Human Use Prnewswire Mirati Therapeutics Inc European Medicine Agency Mirati Therapeutics Inc
Source: marketscreener.com
Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome
Positive opinion from Committee for Medicinal Products for Human Use based on Bylvay Phase III ASSERT clinical-trial data in Alagille syndrome Negative opinion from Committee for Orphan Medicinal...
Source: marketscreener.com
Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome
Positive opinion from Committee for Medicinal Products for Human Use based on Bylvay Phase III ASSERT clinical-trial data in Alagille syndrome Negative opinion from Committee for Orphan Medicinal...
Source: marketscreener.com
Bristol Myers Gets CHMP Backing for Opdivo in Expanded Melanoma Use
By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agencys Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer...
Source: marketscreener.com
Bristol Myers Gets CHMP Backing for Opdivo in Expanded Melanoma Use >BMY
By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded...
Source: marketwatch.com
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jul 21, 2023--
Source: valdostadailytimes.com
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma
Recommendation based on results from the Phase 3 CheckMate -76K trial in patients with stage IIB or IIC melanoma, in which Opdivo demonstrated a statistically significant and clinically meaningful...
Source: marketscreener.com
Merck Receives Positive European Union CHMP Opinion for Gefapixant
Merck , known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of...
United States Joerg Koglin European Medicines Agency Exchange Commission European Commission Merck Co Inc
Source: marketscreener.com
Merck Gets CHMP Backing for Expanded Keytruda Use in Gastrointestinal Cancers >MRK
By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval...
Source: marketwatch.com